The Role of Implantable Defibrillators in Cardiac Resynchronization Therapy in Heart Failure Patients

Moderator:

Discussants:

  • Summary:

    Dr. Barry Massie from the University of California in San Francisco moderated the topic "The Role of Implantable Defibrillators in Cardiac Resynchronization Therapy in Heart Failure Patients" with Drs. John Cleland from the University of Hull, UK, Mark A. Hlatky from Stanford University, and Lynne Stevenson from Harvard Medical School participating.

    The discussion focused primarily on:
    (1) the use of implantable defibrillators as therapeutics and preventative devices,
    (2) benefits versus cost for patients,
    (3) a discussion of which patients which benefit more from these devices,
    (4) the inappropriate use of these devices and the adverse consequences that can arise from them,
    (5) the controversial role of ICDs (implantable cardiac defibrillators) as primary prevention tools,
    (6) the use of ICD in CRT cardiac resynchronization therapy) patients,
    (7) the use of beta-blockers in patients with ICDs, and
    (8) the US guidelines for the use of cardiac pacemakers and anti arrhythmia devices.
    (Med Roundtable Cardiovasc Ed. 2011;2(2):107-116) ©2011 FoxP2 Media, LLC
  • Compounds:
    No compounds discussed.
    Trials:

    CARE-HF, SCD-HeFT, MADIT II, COMPANION

You are not authorized to access this content.

You are not authorized to access this content.
You are not authorized to access this content.
Please subscribe to use our print features or to download PDF files.